Table 2

Adjusted IRRs and 95% CIs for atrial fibrillation according to characteristics of the exposure to the death of a child

ExposureNo of eventsRate/105 person-yearAge-adjusted IRR (95% CI)Multivariable IRR (95% CI)*P value†
Unexposed72 232121.21.001.00
All deaths2473236.41.10 (1.07 to 1.15)1.12 (1.08 to 1.17)
Cause of death of the deceased
 Death due to CVD139569.61.34 (1.13 to 1.58)1.42 (1.20 to 1.69)Reference
 Death due to other causes2334228.51.09 (1.05 to 1.14)1.11 (1.06 to 1.16)<0.0001
Age of the deceased child at loss (in years)
 ≤1624122.11.27 (1.18 to 1.38)1.17 (1.08 to 1.27)0.0118
 2–12337169.71.10 (0.98 to 1.22)1.07 (0.96 to 1.19)0.2041
 13–18193244.00.94 (0.82 to 1.09)0.95 (0.82 to 1.10)Reference
 19–29655370.11.00 (0.93 to 1.08)1.04 (0.96 to 1.13)0.2573
 >29664826.71.14 (1.05 to 1.23)1.26 (1.17 to 1.36)0.0005
No of remaining live children at loss
 0375133.21.25 (1.13 to 1.39)1.13 (1.02 to 1.26)0.5530
 1–21578248.21.09 (1.03 to 1.14)1.09 (1.04 to 1.15)Reference
 ≥3520403.71.07 (0.98 to 1.16)1.21 (1.11 to 1.32)0.0508
No of losses during follow-up‡
 12353228.61.10 (1.06 to 1.15)1.12 (1.07 to 1.17)Reference
 ≥295240.71.10 (0.90 to 1.34)1.12 (0.91 to 1.38)0.9956
  • *Adjusted for sex, age at follow-up, calendar year at follow-up, country of birth, highest educational attainment, history of psychiatric disorders and CVDs.

  • †We tested the differences in the strength of the associations between the different exposure categories and atrial fibrillation risk using the contrast statement in Poisson regression model in SAS. We set as reference group the group who lost a child due to CVDs in the analysis with cause of death, the group who lost a child aged 13–18 years in the analysis with age of the deceased child at loss, the group with 1–2 children left in the analysis with number of remaining live children at loss and the group who lost one child during follow-up in the analysis with the number of losses during follow-up.

  • ‡The analyses were performed among those who had not lost any children before baseline.

  • CI, confidence interval; CVD, cardiovascular diseases; IRR, incidence rate ratio.